- Location
lubiprostone
"-
SPI Subsidiary Sucampo Pharmaceuticals Received Approval in Japan for Amitiza
Dec 5, 2012SPI subsidiary Sucampo Pharmaceuticals has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription drug for the treatment of chronic constipation, excluding constipation caused by ...
Tags: amitiza, lubiprostone, treatment of chronic constipation, prostone
-
Sucampo Has Received a Supplement Approval
Dec 4, 2012Global pharmaceutical company Sucampo has received a supplement approval from the US Food and Drug Administration (FDA) for updates to AMITIZA (lubiprostone) pregnancy labeling. The approval removes pregnancy 'warnings and precautions' ...
Tags: pharmaceutical, supplement, labeling, lubiprostone, FDA, labeling changes
Related Products
-
Chemicals Lubiprostone 333963-40-9 High Quality and Competitive Price
-
Lubiprostone 333963-40-9 High Quality and Competitive Price
-
Lubiprostone CAS 136790-76-6 Health Care High Quality
-
Pharmaceutical Grade API 99% CAS 136790-76-6 Lubiprostone Powder
-
Lubiprostone, CAS 136790-76-6, USP Cp Ep, Lubiprostone Powder
-
Lubiprostone Intermediate, CAS 136790-77-7, Pharmaceutical Intermediate
